Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (23)
COVID-19 (10)
Type
Type
Guidance (827)
NICE advice (136)
Quality standard (74)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (13)
Clinical guidelines (132)
COVID-19 rapid guidelines (2)
Diagnostics guidance (23)
Health technology evaluations (17)
Highly specialised technologies guidance (22)
Interventional procedures guidance (150)
Medical technologies guidance (56)
NICE guidelines (163)
Public health guidelines (11)
Social care guidelines (17)
Technology appraisal guidance (396)
Advice programme
Advice programme
Evidence summaries (12)
Medtech innovation briefings (124)
Apply filters
Showing 51 to 60 of 1037
Sort by
Date
Title
Apply sorting
Last updated date between 1/12/2018 and 23/4/2024
Remove Last updated date between 1/12/2018 and 23/4/2024 filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Sebelipase alfa for treating Wolman disease
HST30
10 January 2024
10 January 2024
Durvalumab with gemcitabine and cisplatin for treating unresectable or advanced biliary tract cancer
TA944
10 January 2024
10 January 2024
Intravascular lithotripsy for calcified arteries in peripheral arterial disease
IPG780
3 January 2024
3 January 2024
Bipolar disorder: assessment and management
CG185
24 September 2014
21 December 2023
Epilepsies in children, young people and adults
QS211
20 December 2023
20 December 2023
Targeted-release budesonide for treating primary IgA nephropathy
TA937
20 December 2023
20 December 2023
Ravulizumab for treating generalised myasthenia gravis (terminated appraisal)
TA940
20 December 2023
20 December 2023
Ravulizumab for treating AQP4 antibody-positive neuromyelitis optica spectrum disorder (terminated appraisal)
TA941
20 December 2023
20 December 2023
Empagliflozin for treating chronic kidney disease
TA942
20 December 2023
20 December 2023
Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes
TA943
19 December 2023
19 December 2023
Previous page
1
…
4
5
Current page
6
7
8
…
104
Page
6
of
104
Next page
Results per page
10
25
50
All
Back to top